Cellect Biotechnology LTD. – American Depositary S (NASDAQ:APOP) Shorts Decreased By 6.53% As Of May 16, 2018

May 16, 2018 - By Mary Kidd

It was reported a decrease on Cellect Biotechnology LTD. – American Depositary S (NASDAQ:APOP)’s shares shorted with 6.53%. FINRA issued shares shorted of APOP’s total 94,400 shares. The 101,000 previous shares are down with 6.53%. Former APOP’s position will need 5 days to restore. It has 18,400 average volume. 0.09% is Cellect Biotechnology LTD. – American Depositary S float short.

The stock increased 0.28% or $0.02 during the last trading session, reaching $7.13.Currently Cellect Biotechnology Ltd. is downtrending after 42.02% change in last May 16, 2017. APOP has 14,223 shares volume. APOP underperformed by 53.57% the S&P500.

Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel.The firm is valued at $46.41 million. It is developing the Apotainer selection kit, a shelf stem cell selection kit, based on its Powered by Cellect technology platform for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies.Last it reported negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: